MOLECULAR AND CELLULAR BIOLOGY OF CYSTIC FIBROSIS
囊性纤维化的分子和细胞生物学
基本信息
- 批准号:3105897
- 负责人:
- 金额:$ 29.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-09-01 至 1994-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Progress towards understanding the etiology of Cystic Fibrosis as well as
in detection and treatment has been substantial in the past few years.
The use of DNA sequences closely linked to the CF locus enables prenatal
diagnosis where there is a family history of the disease and lung
transplantation is extending the life span of some patients. Clues about
the nature of the anion permeability defect responsible for the
pathological changes of epithelial tissues provide some hope that
pharmacological therapies can be developed. The Hospital for Sick
Children has a long term commitment to CF with a very large clinic and
many ongoing research projects both basic and clinical. Some of these
projects constitute a CF research Development Program directed primarily
at the molecular cloning of the CF gene and its expression in sweat gland
epithelial cell culture systems. The present application is intended to
complement this program, to further integrate clinical and basic science
studies and to exploit several strengths of this institution which are
not included in the RDP. The central theme is the understanding of the
basic defect in the different clinical phenotypes of the disease at the
level of DNA haplotypes and ion transport mechanisms in the sweat gland,
the lung and the pancreas. Hence the aims of the research project are; 1)
The identification of a molecular alteration which underlies the apical
chloride permeability defect. 2) The establishment of correlations
between clinical and genetic variations in Cystic Fibrosis. 3) The use of
optical imaging techniques to monitor CF ion transport defects. 4) The
evaluation of the ion transport properties of alveolar epithelial cells
of the lung in CF patients and normal subjects. 5) The examination of the
role of the outwardly rectifying anion channel in pancreatic bicarbonate
secretion 6) The comparison of the properties of this channel in
nonepithelial cells with those in epithelial cells. Two core facilities
will be required by these projects and will also greatly facilitate other
CF projects which are already ongoing. First, the acquisition and culture
of cells from the fetal lung alveolus and pancreatic duct will enable the
cellular and molecular investigations to extend to these tissue. Second,
the CF Biostatistics Core will provide ready access to clinical
parameters of our large CF patient population and thus enable these to be
correlated with properties such as DNA haplotypes and anion channel
function.
囊性纤维化的病因及相关研究进展
在过去的几年里,在检测和治疗方面取得了很大的进展。
使用与CF基因座紧密连锁的DNA序列可以实现产前
有家族病史和肺部疾病的诊断
移植正在延长一些患者的寿命。关于以下方面的线索
阴离子渗透性缺陷的性质导致了
上皮组织的病理变化提供了一些希望
可以开发出药物疗法。生病的医院
儿童基金会拥有一家非常大的诊所,长期致力于儿童基金会
许多正在进行的基础和临床研究项目。其中一些
项目构成了主要指导的CF研究开发计划
Cf基因的分子克隆及其在汗腺中的表达
上皮细胞培养系统。本申请意在
补充这一计划,进一步整合临床和基础科学
学习和利用该机构的几个优势,这些优势是
不包括在RDP中。中心主题是对
本病不同临床表型的基本缺陷
汗腺中DNA单倍型水平和离子传输机制,
肺和胰腺。因此,研究项目的目的是:1)
根尖基础的一种分子改变的鉴定
氯离子渗透性缺陷。2)相关关系的建立
囊性纤维化的临床和遗传变异之间的关系。3)使用
用于监测CF离子传输缺陷的光学成像技术。4)
肺泡上皮细胞离子转运特性的评价
在CF患者和正常人的肺组织中。5)考查
外向整流性阴离子通道在胰腺碳酸氢盐中的作用
分泌物6)该通道特性的比较
非上皮性细胞和上皮性细胞。两个核心设施
将是这些项目所需要的,也将极大地促进其他
Cf已经在进行中的项目。第一,收购和文化
来自胎肺泡和胰管的细胞将使
细胞和分子研究延伸到这些组织。第二,
CF生物统计核心将提供对临床的便捷访问
我们庞大的CF患者群体的参数,从而使这些
与DNA单倍型和阴离子通道等特性相关
功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN R RIORDAN其他文献
JOHN R RIORDAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN R RIORDAN', 18)}}的其他基金
Dynamics and Thermal Stability in CFTR Function and Dysfunction
CFTR 功能和功能障碍的动力学和热稳定性
- 批准号:
8249225 - 财政年份:2012
- 资助金额:
$ 29.6万 - 项目类别:
HTS for Detection of deltaF508 CFTR at the Cell Surface
用于检测细胞表面 deltaF508 CFTR 的 HTS
- 批准号:
7251883 - 财政年份:2005
- 资助金额:
$ 29.6万 - 项目类别:
HTS for Detection of deltaF508 CFTR at the Cell Surface
用于检测细胞表面 deltaF508 CFTR 的 HTS
- 批准号:
7117132 - 财政年份:2005
- 资助金额:
$ 29.6万 - 项目类别:
HTS for Detection of deltaF508 CFTR at the Cell Surface
用于检测细胞表面 deltaF508 CFTR 的 HTS
- 批准号:
6912479 - 财政年份:2005
- 资助金额:
$ 29.6万 - 项目类别:
CFTR and interacting proteins from shark rectal gland
鲨鱼直肠腺的 CFTR 和相互作用蛋白
- 批准号:
6622158 - 财政年份:2002
- 资助金额:
$ 29.6万 - 项目类别:
CFTR and interacting proteins from shark rectal gland
鲨鱼直肠腺的 CFTR 和相互作用蛋白
- 批准号:
6440235 - 财政年份:2002
- 资助金额:
$ 29.6万 - 项目类别:
相似海外基金
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
$ 29.6万 - 项目类别:
Collaborative R&D
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
合理优化治疗罕见囊性纤维化变异的组合疗法
- 批准号:
10736732 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Operating Grants
Analysis of synthetic derivatives with reduced lipophilicity as candidate potentiators towards better treatment alternatives for Cystic Fibrosis
分析亲脂性降低的合成衍生物作为候选增效剂,以获得更好的囊性纤维化治疗替代方案
- 批准号:
481159 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis
开发用于治疗囊性纤维化的基因编辑疗法、可生物降解的聚合物递送载体和高通量平台
- 批准号:
10836095 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
A Ginsenoside TMEM16A Potentiator for Cystic Fibrosis
人参皂苷 TMEM16A 治疗囊性纤维化的增效剂
- 批准号:
10574384 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies
用于基于 mRNA 的囊性纤维化治疗的非病毒基因传递载体的计算启发设计
- 批准号:
10760605 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Health Outcomes of Parents with Cystic Fibrosis (HOPe:CF)
患有囊性纤维化的父母的健康结果 (HOPe:CF)
- 批准号:
10581321 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
Preparation for lung transplant discussions and decisions among people with cystic fibrosis
囊性纤维化患者肺移植讨论和决策的准备
- 批准号:
10657027 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:














{{item.name}}会员




